Spyre Therapeutics(SYRE) - Prospectus(update)

As filed with the Securities and Exchange Commission on February 2, 2024 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 PRE-EFFECTIVE AMENDMENT NO. 1 TO Delaware 46-4312787 (I.R.S. Employer Identification No.) 221 Crescent Street Building 23, Suite 105 Waltham, MA 02453 (617) 651-5940 (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) FORM S-1 REGISTRATION STATEMENT Heidy King-Jones Chief Legal ...